Literature DB >> 33875584

Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.

Guangyong Ma1,2, Jun-Ichirou Yasunaga2,3, Kazuya Shimura2, Keiko Takemoto2, Miho Watanabe3, Masayuki Amano3, Hirotomo Nakata3, Benquan Liu4, Xiaorui Zuo4, Masao Matsuoka5,3.   

Abstract

Human retroviruses, including human T cell leukemia virus type 1 (HTLV-1) and HIV type 1 (HIV-1), encode an antisense gene in the negative strand of the provirus. Besides coding for proteins, the messenger RNAs (mRNAs) of retroviral antisense genes have also been found to regulate transcription directly. Thus, it has been proposed that retroviruses likely localize their antisense mRNAs to the nucleus in order to regulate nuclear events; however, this opposes the coding function of retroviral antisense mRNAs that requires a cytoplasmic localization for protein translation. Here, we provide direct evidence that retroviral antisense mRNAs are localized predominantly in the nuclei of infected cells. The retroviral 3' LTR induces inefficient polyadenylation and nuclear retention of antisense mRNA. We further reveal that retroviral antisense RNAs retained in the nucleus associate with chromatin and have transcriptional regulatory function. While HTLV-1 antisense mRNA is recruited to the promoter of C-C chemokine receptor type 4 (CCR4) and enhances transcription from it to support the proliferation of HTLV-1-infected cells, HIV-1 antisense mRNA is recruited to the viral LTR and inhibits sense mRNA expression to maintain the latency of HIV-1 infection. In summary, retroviral antisense mRNAs are retained in nucleus, act like long noncoding RNAs instead of mRNAs, and contribute to viral persistence.

Entities:  

Keywords:  ASP; HBZ; HIV-1; HTLV-1; RNA-FISH

Mesh:

Substances:

Year:  2021        PMID: 33875584      PMCID: PMC8092383          DOI: 10.1073/pnas.2014783118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  63 in total

1.  Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish.

Authors:  Ariel A Bazzini; Miler T Lee; Antonio J Giraldez
Journal:  Science       Date:  2012-03-15       Impact factor: 47.728

2.  Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences.

Authors:  S Carswell; J C Alwine
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

3.  Tailing and 3'-end labeling of RNA with yeast poly(A) polymerase and various nucleotides.

Authors:  G Martin; W Keller
Journal:  RNA       Date:  1998-02       Impact factor: 4.942

4.  The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription.

Authors:  Gilles Gaudray; Frederic Gachon; Jihane Basbous; Martine Biard-Piechaczyk; Christian Devaux; Jean-Michel Mesnard
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions.

Authors:  Ci Chu; Kun Qu; Franklin L Zhong; Steven E Artandi; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-29       Impact factor: 17.970

6.  Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.

Authors:  C Van Lint; S Emiliani; M Ott; E Verdin
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

7.  P53 mRNA controls p53 activity by managing Mdm2 functions.

Authors:  Marco M Candeias; Laurence Malbert-Colas; Darren J Powell; Chrysoula Daskalogianni; Magda M Maslon; Nadia Naski; Karima Bourougaa; Fabien Calvo; Robin Fåhraeus
Journal:  Nat Cell Biol       Date:  2008-09       Impact factor: 28.824

8.  5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals.

Authors:  Takaomi Ishida; Akiko Hamano; Tsukasa Koiwa; Toshiki Watanabe
Journal:  Retrovirology       Date:  2006-10-12       Impact factor: 4.602

9.  Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia.

Authors:  Thomas Trimarchi; Erhan Bilal; Panagiotis Ntziachristos; Giulia Fabbri; Riccardo Dalla-Favera; Aristotelis Tsirigos; Iannis Aifantis
Journal:  Cell       Date:  2014-07-31       Impact factor: 41.582

10.  Coding and Non-coding RNAs, the Frontier Has Never Been So Blurred.

Authors:  Florent Hubé; Claire Francastel
Journal:  Front Genet       Date:  2018-04-18       Impact factor: 4.599

View more
  7 in total

Review 1.  HIV UTR, LTR, and Epigenetic Immunity.

Authors:  Jielin Zhang; Clyde Crumpacker
Journal:  Viruses       Date:  2022-05-18       Impact factor: 5.818

2.  Identification and mapping of post-transcriptional modifications on the HIV-1 antisense transcript Ast in human cells.

Authors:  Mariana Estevez; Rui Li; Biplab Paul; Kaveh Daneshvar; Alan C Mullen; Fabio Romerio; Balasubrahmanyam Addepalli
Journal:  RNA       Date:  2022-02-15       Impact factor: 5.636

Review 3.  Functional and Pathogenic Roles of Retroviral Antisense Transcripts.

Authors:  Kosuke Toyoda; Masao Matsuoka
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

Review 4.  Retroviral Antisense Transcripts and Genes: 33 Years after First Predicted, a Silent Retroviral Revolution?

Authors:  Roger H Miller; Alexis Zimmer; Gilles Moutot; Jean-Michel Mesnard; Nathalie Chazal
Journal:  Viruses       Date:  2021-11-04       Impact factor: 5.048

Review 5.  Current Perspectives in Human T-Cell Leukemia Virus Type 1 Infection and Its Associated Diseases.

Authors:  Michi Miura; Tadasuke Naito; Mineki Saito
Journal:  Front Med (Lausanne)       Date:  2022-04-08

Review 6.  The Road to HTLV-1-Induced Leukemia by Following the Subcellular Localization of HTLV-1-Encoded HBZ Protein.

Authors:  Roberto S Accolla
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

Review 7.  Latency Reversing Agents: Kick and Kill of HTLV-1?

Authors:  Annika P Schnell; Stephan Kohrt; Andrea K Thoma-Kress
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.